FERLENGHI, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 1.920
EU - Europa 1.494
AS - Asia 1.482
SA - Sud America 214
Continente sconosciuto - Info sul continente non disponibili 80
AF - Africa 76
OC - Oceania 2
Totale 5.268
Nazione #
US - Stati Uniti d'America 1.866
IT - Italia 715
SG - Singapore 555
CN - Cina 317
VN - Vietnam 252
BR - Brasile 166
IE - Irlanda 147
DE - Germania 128
SE - Svezia 113
HK - Hong Kong 111
FR - Francia 61
BD - Bangladesh 59
ZA - Sudafrica 55
AT - Austria 53
IN - India 53
GB - Regno Unito 51
RU - Federazione Russa 37
NL - Olanda 36
BE - Belgio 28
FI - Finlandia 25
CA - Canada 24
AR - Argentina 20
CZ - Repubblica Ceca 19
TR - Turchia 19
ID - Indonesia 18
MX - Messico 18
PL - Polonia 15
ES - Italia 14
JP - Giappone 14
KR - Corea 14
UA - Ucraina 14
PK - Pakistan 11
HU - Ungheria 9
CI - Costa d'Avorio 8
CO - Colombia 8
IQ - Iraq 8
PH - Filippine 8
TH - Thailandia 8
LU - Lussemburgo 7
RS - Serbia 6
UZ - Uzbekistan 6
VE - Venezuela 6
JO - Giordania 5
LT - Lituania 5
RO - Romania 5
CL - Cile 4
MA - Marocco 4
TW - Taiwan 4
DZ - Algeria 3
EC - Ecuador 3
IL - Israele 3
PY - Paraguay 3
BO - Bolivia 2
MN - Mongolia 2
MY - Malesia 2
NP - Nepal 2
PS - Palestinian Territory 2
SN - Senegal 2
SV - El Salvador 2
TN - Tunisia 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
AU - Australia 1
BZ - Belize 1
CH - Svizzera 1
CR - Costa Rica 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
IR - Iran 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
KW - Kuwait 1
MD - Moldavia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PW - Palau 1
SA - Arabia Saudita 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 5.189
Città #
Singapore 327
Ashburn 239
Ann Arbor 209
Dallas 196
Chandler 188
Parma 167
San Jose 152
Dublin 141
Hong Kong 102
Santa Clara 95
Ho Chi Minh City 81
Beijing 73
Council Bluffs 68
Los Angeles 61
Boardman 53
Johannesburg 52
Hanoi 51
New York 43
Vienna 43
Shanghai 42
Bologna 38
Milan 36
Munich 36
Hefei 35
Modena 25
Rome 25
Brescia 22
Lauterbourg 21
Princeton 20
Bremen 19
Helsinki 19
Columbus 18
São Paulo 17
The Dalles 17
Buffalo 16
Brussels 15
Frankfurt am Main 15
Wilmington 15
Guangzhou 14
Jakarta 14
Moscow 14
London 13
Tokyo 12
Brno 11
Haiphong 11
Prata Di Pordenone 11
Stockholm 11
Ankara 10
Nuremberg 10
Orem 10
Seoul 10
Da Nang 9
Des Moines 9
Toronto 9
Vigevano 9
Warsaw 9
Abidjan 8
Chennai 8
Jinan 8
Leuven 8
Manchester 8
Nanjing 8
Pune 8
Atlanta 7
Montegaldella 7
Palermo 7
Phoenix 7
Rio de Janeiro 7
Shenyang 7
Belo Horizonte 6
Brooklyn 6
Dearborn 6
Denver 6
Follonica 6
Fremont 6
Houston 6
Hyderabad 6
Lahore 6
Mexico City 6
Montreal 6
Naples 6
Neviano degli Arduini 6
Segrate 6
Soliera 6
Verona 6
Bari 5
Belgrade 5
Chicago 5
Collecchio 5
Fairfield 5
Poplar 5
Querétaro 5
Rimini 5
Salerno 5
San Francisco 5
San Mateo 5
Tashkent 5
Thái Nguyên 5
Turku 5
Amman 4
Totale 3.256
Nome #
Balancing reactivity and antitumor activity: heteroarylthioacetamide derivatives as potent and time-dependent inhibitors of EGFR 353
Benzisothiazolinone Derivatives as Potent Allosteric Monoacylglycerol Lipase Inhibitors That Functionally Mimic Sulfenylation of Regulatory Cysteines 278
Targeting glucosylceramide synthase induces antiproliferative and proapoptotic effects in osimertinib-resistant NSCLC cell models 249
Inhibition of Eph/ephrin interaction with the small molecule UniPR500 improves glucose tolerance in healthy and insulin-resistant mice 244
Antidepressant-like effects of pharmacological inhibition of FAAH activity in socially isolated female rats 242
Pharmacological evaluation of new bioavailable small molecules targeting Eph/ephrin interaction 228
Drug-gut microbiota metabolic interactions: the case of UniPR1331, selective antagonist of the Eph-ephrin system, in mice 221
Expanding the Arsenal of FGFR Inhibitors: A Novel Chloroacetamide Derivative as a New Irreversible Agent With Anti-proliferative Activity Against FGFR1-Amplified Lung Cancer Cell Lines. 220
Optimization of EphA2 antagonists based on a lithocholic acid core led to the identification of UniPR505, a new 3α-carbamoyloxy derivative with antiangiogenetic properties 220
Social stress-induced depressive-like symptoms and changes in gut microbial and lipidomic profiles are prevented by pharmacological inhibition of FAAH activity in male rats 219
Chemical modification of NSC12 leads to a specific FGF-trap with antitumor activity in multiple myeloma 218
Metabolic Soft Spot and Pharmacokinetics: Functionalization of C-3 Position of an Eph–Ephrin Antagonist Featuring a Bile Acid Core as an Effective Strategy to Obtain Oral Bioavailability in Mice 215
(2S,4R)-4-fluoroglutamine is converted into (2S,4R)-4-fluoroglutamate by glutaminase activity and may be exploited as a PET tracer in glutamine-addicted cancers 214
A sulfonyl fluoride derivative inhibits EGFR L858R/T790M/C797S by covalent modification of the catalytic lysine 208
Cell-targeted c(AmpRGD)-sunitinib molecular conjugates impair tumor growth of melanoma 195
Steps towards sustainable solid phase peptide synthesis: use and recovery ofN-octyl pyrrolidone 176
Protein-Protein Interaction Inhibitors Targeting the Eph-Ephrin System with a Focus on Amino Acid Conjugates of Bile Acids 165
N-(Anilinoethyl)amide Melatonergic Ligands with Improved Water Solubility and Metabolic Stability 164
Eph/ephrin targeting with a small molecule improves glucose tolerance in healthy and insulin-resistant mice 160
Palladium Catalyst Recycling for Heck-Cassar-Sonogashira Cross-Coupling Reactions in Green Solvent/Base Blend 154
Expanding the knowledge around antitubercular 5-(2-aminothiazol-4-yl)isoxazole-3-carboxamides: Hit–to–lead optimization and release of a novel antitubercular chemotype via scaffold derivatization 143
Role of sphingolipid metabolism in osimertinib-resistance in EGFR-mutated NSCLC models 137
Design, Synthesis, and Physicochemical and Pharmacological Profiling of 7-Hydroxy-5-oxopyrazolo[4,3-b]pyridine-6-carboxamide Derivatives with Antiosteoarthritic Activity in Vivo 136
Identification of Human Alanine-Glyoxylate Aminotransferase Ligands as Pharmacological Chaperones for Variants Associated with Primary Hyperoxaluria Type 1 132
The role of organic acid counterions in modulating the in-vitro dissolution and permeability profiles of procaine salts 126
Enhancement of peripheral fatty acyl ethanolamide signaling prevents stress‑induced social avoidance and anxiety‑like behaviors in male rats 119
The GABAB receptor positive allosteric modulator COR659: In vitro metabolism, in vivo pharmacokinetics in rats, synthesis and pharmacological characterization of metabolically protected derivatives 107
Salts with Organic acids to explore the Impact of Ion-Pair Stability on Dissolution rate and Permeability of Procaine 17
An integrated approach for physico-chemical profiling in drug discovery 8
Totale 5.268
Categoria #
all - tutte 17.070
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.070


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022277 0 18 16 49 22 5 38 24 30 20 11 44
2022/2023732 57 76 54 75 70 88 12 58 175 29 29 9
2023/2024396 21 15 19 5 21 55 38 30 26 40 67 59
2024/2025966 38 42 61 103 79 79 85 64 109 80 86 140
2025/20262.164 187 225 266 218 286 121 211 75 241 167 96 71
2026/2027118 61 57 0 0 0 0 0 0 0 0 0 0
Totale 5.268